Advanced search
Publication Cover
Biologics: Targets and Therapy Volume 2, 2008 - Issue 4
Submit an article Journal homepage
49
Views
5
CrossRef citations to date
0
Altmetric
Review

Rituximab in the treatment of non-Hodgkin’s lymphoma

Beate HauptrockHematology/Oncology, Johannes Gutenberg-University, Mainz, Germany
&
Georg HessHematology/Oncology, Johannes Gutenberg-University, Mainz, GermanyCorrespondence[email protected]
Pages 619-633 | Published online: 05 Dec 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Pragya Shrestha, Ian Garrahy & Shoja Rahimian. (2020) Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease. Journal of Community Hospital Internal Medicine Perspectives 10:6, pages 600-603.
Read now
Yang Yu & Raghav Govindarajan. (2020) Intravascular large B-cell lymphoma presenting as an isolated cauda equina–conus medullaris syndrome – A case report. The Journal of Spinal Cord Medicine 43:4, pages 556-559.
Read now
Jing Wang, Min Zhou, Jing-Yan Xu, Bing Chen & Jian Ouyang. (2015) Combination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma. OncoTargets and Therapy 8, pages 2645-2650.
Read now
David Maloney, Franck Morschhauser, Ola Linden, Anton Hagenbeek & Christian Gisselbrecht. (2010) Diversity in antibody-based approaches to non-Hodgkin lymphoma. Leukemia & Lymphoma 51:sup1, pages 20-27.
Read now

Articles from other publishers (1)

Qiang Dai, Ping Han, Xinyue Qi, Fanlin Li, Min Li, Lilv Fan, Huihui Zhang, Xiaoqing Zhang & Xuanming Yang. (2020) 4-1BB Signaling Boosts the Anti-Tumor Activity of CD28-Incorporated 2nd Generation Chimeric Antigen Receptor-Modified T Cells. Frontiers in Immunology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.